Cost-effectiveness analysis of pneumococcal conjugate vaccines in preventing pneumonia in Peruvian children | Zendy

Edward MezonesHolguín | Zendy; Rafael Bolaños-Díaz | Zendy; Víctor Fiestas Solórzano | Zendy; C Sanabria | Zendy; Alfonso Gutiérrez-Aguado | Zendy; Fabián Fiestas | Zendy; Víctor Suárez | Zendy; Alfonso J. RodríguezMorales | Zendy; Adrían V. Hernández | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cost-effectiveness analysis of pneumococcal conjugate vaccines in preventing pneumonia in Peruvian children

Author(s) -

Edward MezonesHolguín,

Rafael Bolaños-Díaz,

Víctor Fiestas Solórzano,

C Sanabria,

Alfonso Gutiérrez-Aguado,

Fabián Fiestas,

Víctor Suárez,

Alfonso J. RodríguezMorales,

Adrían V. Hernández

Publication year - 2014

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.5855

Subject(s) - medicine , pneumococcal conjugate vaccine , pneumonia , pediatrics , environmental health , streptococcus pneumoniae , genetics , bacteria , biology

Pneumococcal pneumonia (PP) has a high burden of morbimortality in children. Use of pneumococcal conjugate vaccines (PCVs) is an effective preventive measure. After PCV 7-valent (PCV7) withdrawal, PCV 10-valent (PCV10) and PCV 13-valent (PCV13) are the alternatives in Peru. This study aimed to evaluate cost effectiveness of these vaccines in preventing PP in Peruvian children <5 years-old.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research